GL1X · GenesisL1 explorer

Research workbench

Human ppargamma ligand-binding domain in complex with indomethacin and nitro-233

Analyse Human ppargamma ligand-binding domain in complex with indomethacin and nitro-233 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3ADX
Type
protein
Length
525 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma
UniProt
P37231
Ligands
IMN, NRO
Pockets
11 · best druggability 0.85

Structure

x-ray diffraction · 2 distinct chains · 68% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein27466% helix, 5% strandP37231
BPeroxisome proliferator-activated receptor gammaprotein25171% helix, 5% strandP37231

Ligands and binding sites

  • IMN · Indomethacin · ligand · 2 copies · chains A, B
  • NRO · 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15200.850.9158NRO, IMN
24900.790.8652IMN
31250.600.8617empty
41390.570.8324empty
52240.550.7823empty

Interfaces

1 interface between chains.

  • A–B · 985 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 3ADX · Human PPARgamma ligand-binding domain in complex with indomethacin and nitro-233 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.